Stock Events

Stock Events

BioXcel Therapeutics (BX20.F) Q2 2026 Earnings

May 15Confirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-2.45

-1.79

-1.12

-0.46

Details

Expected EPS

-0.458051175

Actual EPS

-0.46450260000000004

Surprise EPS

-0.01

Surprise Percent

-1.41%

Description

⁨BioXcel Therapeutics⁩ (⁦BX20.F⁩) has reported earnings of ⁦-0.46450260000000004⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.